TITLE

Percutaneous Closure of Left Atrial Appendage vs Warfarin Therapy

AUTHOR(S)
Karpman, Harold L.
PUB. DATE
October 2009
SOURCE
Internal Medicine Alert;10/15/2009, Vol. 31 Issue 19, p146
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The efficacy of percutaneous closure of the LAA with the WATCHMAN® left atrial closure device was found to be non-inferior to that of standard warfarin therapy for prevention of stroke, cardiovascular death, and/or systemic embolism and, therefore, the device might provide an alternative strategy to chronic warfarin therapy for stroke prophylaxis in patients with non-valvular atrial fibrillation.
ACCESSION #
44960610

 

Related Articles

  • PERCUTANEOUS CLOSURE OF LEFT ATRIAL APPENDAGE MAY DECREASE RISK OF DEATH AND HEMORRHAGIC STROKE COMPARED WITH WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION. Ehrlich, Alan // Clinical Advisor;Mar2015, Vol. 18 Issue 3, p76 

    No abstract available.

  • Left Atrial Appendage Occlusion vs Warfarin for Nonvalvular AF. Boyle, Andrew T. // Clinical Cardiology Alert;Apr2013, Vol. 32 Issue 4, p25 

    The article discusses the effectiveness of the left atrial appendage occlusion and an anticoagulant Warfarin which prevents blood clot formation in nonvalvular atrial fibrillation (AF). It states that the left atrial appendage (LAA) is a place where thrombus can breed and that results in stroke...

  • Catheter-based left atrial appendage occlusion procedure: role of echocardiography. Perk, Gila; Biner, Simon; Kronzon, Itzhak; Saric, Muhamed; Chinitz, Larry; Thompson, Keith; Shiota, Takahiro; Hussani, Asma; Lang, Roberto; Siegel, Robert; Kar, Saibal // European Heart Journal - Cardiovascular Imaging;Feb2012, Vol. 13 Issue 2, p132 

    Atrial fibrillation is a common, clinically significant arrhythmic disorder that results in increased risk of morbidity and mortality in affected patients. Atrial fibrillation is more prevalent among men compared with women and the risk for developing atrial fibrillation increases with advancing...

  • Cost effectiveness of therapies for atrial fibrillation. A review. Teng, M.P.; Catherwood, E.; Melby, D.P.; Catherwood, L E // PharmacoEconomics;2000, Vol. 18 Issue 4, p317 

    Atrial fibrillation is the most common supraventricular tachyarrhythmia encountered in clinical practice, affecting over 5% of persons over the age of 65 years. A common pathophysiological mechanism for arrhythmia development is atrial distention and fibrosis induced by hypertension, coronary...

  • If in left human atrium: a potential contributor to atrial ectopy Zorn-Pauly, Klaus; Schaffer, Peter; Pelzmann, Brigitte; Lang, Petra; Mächler, Heinrich; Rigler, Bruno; Koidl, Bernd // Cardiovascular Research;Nov2004, Vol. 64 Issue 2, p250 

    The left human atrium plays an important role in initiation of atrial fibrillation (AF) and the hyperpolarization activated cation current (If) is a candidate for contributing to abnormal automaticity. However, electrophysiological data concerning If are not available in this cardiac region and...

  • Left Atrial Appendage Occlusion vs Warfarin for Nonvalvular AF. Boyle, Andrew J. // Hospital Medicine Alert;May2013, Vol. 8 Issue 3, p22 

    The article discusses the effect of warfarin on left atrial appendage occlusion for nonvalvular atrial fibrillation (AF). It states that AF is a major source of morbidity. It also mentions that in presence of thromboembolism risk factors, AF is associated with an increased risk of stroke which...

  • The case of stroke prevention by left atrial appendage occlusion in patients with atrial fibrillation--can we close the file? Blaauw, Yuri; Rienstra, Michiel // Journal of Thoracic Disease;2015, Vol. 7 Issue 10, p1696 

    No abstract available.

  • Atrial fibrillation. Pinkowish, Mary Desmond // Patient Care;3/15/1999, Vol. 33 Issue 5, p162 

    Focuses on atrial fibrillation, its causes, diagnosis and management. Prevention of stroke; Control of ventricular rate; Restoration of sinus rhythm; Maintenance of sinus rhythm; Management of a first episode of atrial fibrillation; Drugs used in the treatment of atrial fibrillation.

  • Cardiovascular highlights from non-cardiology journals. Bradley, Steven M. // Heart;Mar2015, Vol. 101 Issue 5, p408 

    A review is offered for the articles "Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction" by TM Maddox and others, and "Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation: A Randomized Clinical Trial" by VY Reddy and others, that were published...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics